TrialThe Prostate2026

The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC.

Kohei Hashimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.